Letrowise Tablet
Marketer
Medwise Overseas Pvt Ltd
Salt Composition
Letrozole (2.5mg)
Overview Letrowise Tablet
Postmenopausal women with breast cancer may find relief with Letrowise Tablets. This medication can be administered independently or in conjunction with surgical or radiation therapies. In advanced breast cancer, it aids in preventing metastasis. Letrowise Tablets can be ingested with or without food, always following the physician's prescribed dosage and duration for optimal results. Dosage frequency varies depending on the treatment plan; your doctor will determine the appropriate amount to manage your condition. Continue taking the medication as directed. Common side effects include hot flashes, tiredness, excessive sweating, and elevated cholesterol. Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or history of osteoporosis. Disclose all current medications, as interactions may affect Letrowise's efficacy. Pregnant or breastfeeding women should consult their physician before use. Blood tests, possibly assessing vitamin D levels and bone density, may be conducted before and throughout the treatment period.
Primary Ingredients of Letrowise Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Letrowise Tablet
Managing breast cancer
Major Benefits of Letrowise Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Letrowise Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Letrowise Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Letrowise Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letrowise Tablet can be consumed with or without food, though consistent timing is recommended.
How Letrowise Tablet works:
Letrowise tablets function as an aromatase inhibitor, reducing the body's estrogen production—a key female hormone. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Letrowise Tablet and alcohol consumption.
PregnancyUNSAFE
Using Letrowise Tablet during pregnancy is strongly contraindicated. Pregnant individuals should consult their physician; research in animal and human studies reveals substantial risks to the fetus.
Breast feedingUNSAFE
Nursing mothers should avoid Letrowise Tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking Letrowise Tablets may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Letrowise Tablets is considered safe for individuals with kidney disease, and no dosage alteration is typically necessary. Nevertheless, data regarding its use in patients experiencing end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Letrowise Tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Letrowise Tablet :
Should you forget a Letrowise Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Letrowise Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |


